MNEMO THERAPEUTICS
Mnemo Therapeutics specializes in biotechnology and life science.
MNEMO THERAPEUTICS
Industry:
Biotechnology
Founded:
2019-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.mnemo-tx.com
Status:
Active
Total Funding:
89.96 M USD
Current Employees Featured
Founder
Investors List
Casdin Capital
Casdin Capital investment in Series A - Mnemo Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series A - Mnemo Therapeutics
Emerson Collective
Emerson Collective investment in Series A - Mnemo Therapeutics
Redmile Group
Redmile Group investment in Series A - Mnemo Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Mnemo Therapeutics
Casdin Capital
Casdin Capital investment in Seed Round - Mnemo Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-23 | Mnemo Therapeutics Names Robert LaCaze as Chief Executive Officer |
Official Site Inspections
http://www.mnemo-tx.com Semrush global rank: 5.17 M Semrush visits lastest month: 1.56 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Mnemo Therapeutics"
Mnemo Tx | Biotech | Paris : Developing a robust, tumour-specific ...
Our pioneering approach exploits a rich, unexplored source of druggable targets that are both tumor specific and shared across patients. Mnemo Therapeutics is a Paris-based …See details»
About Us v2 | Mnemo Tx
At Mnemo, we focus on improving patient treatment outcomes in devastating diseases with unmet need. We believe the future of medicine lies in the integration of interdisciplinary approaches, …See details»
Mnemo Therapeutics - Crunchbase Company Profile
Mnemo Therapeutics is a biotechnology company that offers to develop immune based therapies, including cell therapies. Its EnfiniT platform is a drug discovery engine that uses a class of antigens with a suite of technologies for tumors.See details»
Contact - Mnemo Tx
If you are interested by the scientific discoveries at Mnemo Tx, reach out to us.See details»
Mnemo Therapeutics — Sofinnova Partners
Mnemo is developing powerful cell therapies using a novel target identification engine, stronger T cells and best-in-class manufacturing. The company is accelerating development of the …See details»
Mnemo Therapeutics Company Profile - Office Locations ... - Craft
See insights on Mnemo Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Mnemo Therapeutics and Institut Curie announc | EurekAlert!
Paris, February 3, 2023 – Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, has announced publication of two groundbreaking scientific …See details»
Mnemo Therapeutics and Institut Curie Announce Two Key …
Feb 3, 2023 · To learn more, visit https://mnemo-tx.com and follow Mnemo Therapeutics on Twitter (@MnemoTx) and LinkedIn. Institut Curie, France's leading cancer centre, combines …See details»
Mnemo Therapeutics - Overview, News & Similar companies
Feb 2, 2023 · Founded in 2019, based out of Paris, France, Mnemo Therapeutics is a biotechnology company focused on developing powerful cell therapies that create accessible …See details»
Inactivation of Suv39h1 Enhances Anti-Tumor Immune …
Jul 6, 2022 · Mnemo is developing transformational immunotherapies to improve the body's ability to fight and overcome cancer. Integral to Mnemo's approach is the EnfiniT Discovery Engine, composed of key...See details»
Scientific Platform v2 | Mnemo Tx
Mnemo Therapeutics’ E-antigen Platform identifies new cancer-specific drug targets and develops highly effective, safe and scalable immunotherapies.See details»
Mnemo Therapeutics Appoints Christine Foster, Ph.D. and Co …
PARIS, Nov. 30, 2022 /PRNewswire/ -- Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, today announced the appointment of Christine …See details»
Mnemo Therapeutics Announces €75 million Series A to
Jun 16, 2021 · Mnemo Therapeutics, a biotechnology company developing powerful cell therapies using a novel target identification engine, stronger T cells and best-in-class manufacturing, …See details»
Mnemo Therapeutics Announces €75 million Series A to …
PARIS, June 16, 2021 /PRNewswire/ -- Mnemo Therapeutics, a biotechnology company developing powerful cell therapies using a novel target identification engine, stronger T cells …See details»
Mnemo Therapeutics Announces Publication in Cancer Discovery …
Nov 7, 2023 · Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, has announced a new preclinical study showing that CAR T cell memory …See details»
Scientific Publications - Mnemo Tx
See how our science is showcased in recent publications from major journalsSee details»
Org Chart Mnemo-Tx - The Official Board
Unfortunately, you don't own enough credit to see this new org chart. To continue, you can add a name in one of the org charts you recently viewed or test our Premium membership.See details»
Mnemo Therapeutics Announces Publication in Cancer Discovery …
PARIS, Nov. 7, 2023 /PRNewswire/ -- Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, has announced a new preclinical study showing that CAR …See details»
Research Demonstrates Novel HIT Receptor Enhances T cell
Jan 24, 2022 · Mnemo Therapeutics is a biotechnology company focused on the development of powerful new cell therapies. With its EnfiniT platform, Mnemo applies a novel, integrated …See details»
All Products - Mnemo Tx
See all news from Mnemo Therapeutics. See all news from Mnemo Thera peuti cs … Read more. 12 productsSee details»